Literature DB >> 445428

Regional blood flow in human tumors.

M J Mäntylä.   

Abstract

Blood flow in 97 human tumor nodules, of which 31 were lymphomas, 31 were anaplastic carcinomas, and 35 were differentiated cancers, was measured using the 133Xe clearance method. The lymphomas showed statistically higher blood flow [34.6 +/- 21 (S.D.) ml/min/100 g] than did the anaplastic carcinomas (15.4 +/- 11.4 ml/min/100 g; p less than 0.001) and the differentiated cancers (22.8 +/- 14.9 ml/min/100 g; p less than 0.05). The size of the tumors did not correlate with the blood flow. In the group of differentiated cancers, the blood flow in nodules in areas of earlier irradiation was lower (9.0 +/- 6.3 ml/min/100 g) than in nodules in intact regions (25.0 +/- 14.5 ml/min/100 g; p less than 0.05). Nodules in cicatricial areas after surgical operation had lower blood flow than did nodules in the intact areas, but the difference is not statistically significant. It is obvious that most human tumors have a considerably lower blood flow than what one would expect to find in the surrounding normal tissue.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 445428

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Physiologically-based pharmacokinetics and molecular pharmacodynamics of 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite in tumor-bearing mice.

Authors:  Lu Xu; Julie L Eiseman; Merrill J Egorin; David Z D'Argenio
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-06       Impact factor: 2.745

3.  Comparison of cellular basis of drug sensitivity of human colon, pancreatic, and renal carcinoma cell lines with that of leukemia cell lines.

Authors:  S Ozawa; T Yasuda; M Inaba
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 4.  Blood flow and oxygenation status of human tumors. Clinical investigations.

Authors:  H J Feldmann; M Molls; P Vaupel
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

Review 5.  Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.

Authors:  L H Patterson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

6.  Mechanism and control of degradation and resynthesis of adenylates in tumour cells.

Authors:  Z Kovacević; O Brkljac; D Jerance
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

7.  Measurement of blood supply to murine tumours using in vivo red cell labelling and dynamic scintigraphy.

Authors:  G M Baker; M B Clarke; W F Whimster
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

8.  Radiation effects on uptake of 99Tcm-hexamethylpropylen amine oxime (HMPAO) in head and neck tumours.

Authors:  H Minn; A Ahonen; R Paul
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.